Medically reviewed by the Celva medical team · July 2026
The podcasts made it famous.
Here is the fuller picture.
Joe Rogan and his guests have talked for years about getting stem cell therapy in Tijuana and Mexico, and those conversations are why many patients start researching. Rogan has no affiliation with Celva and has not endorsed any clinic named here. This page is for the research he inspired: what the shows get right, what they skip, and how to vet a clinic yourself.
Expanded stem cell treatment is not FDA-approved in the US, so athletes and patients describe going abroad for it.
Candidacy screening is the part of this field podcasts skip. It is also the part that protects you.
What the podcasts
get right.
The broad strokes of the on-air story hold up.
The regulatory picture is real: expanded mesenchymal stem cell (MSC) treatment is not FDA-approved, so Americans who want it travel, most often to Mexico and Panama. The mechanism the guests describe, cells that signal and calm inflammation rather than instantly rebuild tissue, matches how researchers actually talk about MSCs. And the athlete stories reflect a real pattern: recovery and joint problems are the most common reasons patients go.
You have to leave the US for it
Expanded-cell protocols are not FDA-approved. Tijuana is the closest serious destination to the western US.
Cells signal, they do not patch
MSCs work through signaling over weeks and months. Guests who describe gradual change are describing it accurately.
Joints and recovery lead the field
Knees, hips, shoulders, and backs are the bulk of real-world cases, athletes and non-athletes alike.
What a two-hour conversation
still skips.
A podcast tells one person's story. Your decision needs the parts that never make the edit.
The stories you hear are from people who were treated. You do not hear from the people a careful clinic turned away, and that screen is the single best predictor of how seriously a clinic takes medicine. You also do not hear that clinics differ enormously: in where treatment happens, in how cells are sourced and tested, and in whether anyone reads your imaging before quoting you a package.
And results vary. Some patients report large improvements, some partial, some little. Any clinic that leads with a guarantee has answered the seriousness question for you.
Candidacy is a medical decision
Imaging and history decide whether treatment is reasonable. Some cases belong with a surgeon instead.
Clinics are not interchangeable
Hospital setting or storefront. Tested cells or a shrug. The label "Tijuana stem cells" covers both.
Results vary, and honest clinics say so
One famous person's outcome is a story, not a forecast for your knee.
How to vet a Tijuana clinic,
whoever you choose.
Four questions separate the serious operations from the rest. Ask them anywhere you are considering, including here.
Where does treatment actually happen?
A full hospital with real infrastructure, or a standalone suite? Ask what happens if something goes wrong on the day.
Will a physician read your imaging before you travel?
If the answer to every inquiry is yes, that is a sales process, not an evaluation. Ask what share of inquiries are declined.
Where do the cells come from, and who tested them?
Sourcing, processing, and release testing should have plain answers. Vague answers about the product are disqualifying.
Can they explain the price before you commit?
You should understand what shapes the number: cell type, dose, areas treated. Surprise line items are a warning sign.
The homework,
already organized.
Curiosity is a fine
starting point.
If a podcast started your research, finish it properly: a physician reviewing your imaging and telling you plainly whether regenerative treatment is a realistic option. If it is not, we will say so.